Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)

被引：49

作者：

Broussy, Sylvain ^{[1
]}

Laaroussi, Hanna ^{[1
]}

Vidal, Michel ^{[1
,2
]}

机构：

[1] Univ Paris, Fac Pharm Paris, CiTCoM, INSERM,8038 CNRS,U1268, F-75006 Paris, France

[2] Hop Cochin, AP HP, Serv Biol Medicament Toxicol, Paris, France

来源：

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2020年 / 35卷 / 01期

关键词：

SIRT1; EX-527; enzyme inhibition; cell-based and in vivo biological assays; HISTONE DEACETYLASE SIRT1; CANCER-CELLS; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; P53; ACETYLATION; DISCOVERY; SIRTUINS; POTENT; EXPRESSION; APOPTOSIS;

D O I：

10.1080/14756366.2020.1758691

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The human sirtuin silent information regulator 1 (SIRT1) is a NAD(+)-dependent deacetylase enzyme. It deacetylates many protein substrates, including histones and transcription factors, thereby controlling many physiological and pathological processes. Several synthetic inhibitors and activators of SIRT1 have been developed, and some therapeutic applications have been explored. The indole EX-527 and its derivatives are among the most potent and selective SIRT1 inhibitors. EX-527 has been often used as a pharmacological tool to explore the effect of SIRT1 inhibition in various cell types. Its therapeutic potential has, therefore, been evaluated in animal models for several pathologies, including cancer. It has also been tested in phase II clinical trial for the treatment of Huntington's disease (HD). In this review, we will provide an overview of the literature on EX-527, including its mechanism of inhibition and biological studies.

引用

页码：1124 / 1136

页数：13

共 93 条

[61] The biochemistry of sirtuins [J].

Sauve, Anthony A. ;

Wolberger, Cynthia ;

Schramm, Vern L. ;

Boeke, Jef D. .

ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :435-465

[62] Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines [J].

Schnekenburger, Michael ;

Goffin, Eric ;

Lee, Jin-Young ;

Jang, Young ;

Mazurnder, Aloran ;

Ji, Seungwon ;

Rogister, Bernard ;

Bouider, Nafila ;

Lefranc, Florence ;

Miklos, Walter ;

Mathieu, Veronique ;

de Tullio, Pascal ;

Kirn, Kyu-Won ;

Dicato, Mario ;

Berger, Walter ;

Han, Byung Woo ;

Kiss, Robert ;

Pirotte, Bernard ;

Diederich, Marc .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (11) :4714-4733

[63] Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes [J].

Schuster, Susanne ;

Penke, Melanie ;

Gorski, Theresa ;

Petzold-Quinque, Stefanie ;

Damm, Georg ;

Gebhardt, Rolf ;

Kiess, Wieland ;

Garten, Antje .

PLOS ONE, 2014, 9 (03)

[64] A continuous microplate assay for sirtuins and nicotinamide-producing enzymes [J].

Smith, Brian C. ;

Hallows, William C. ;

Denu, John M. .

ANALYTICAL BIOCHEMISTRY, 2009, 394 (01) :101-109

[65] A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease [J].

Smith, Marianne R. ;

Syed, Adeela ;

Lukacsovich, Tamas ;

Purcell, Judy ;

Barbaro, Brett A. ;

Worthge, Shane A. ;

Wei, Stephen R. ;

Pollio, Giuseppe ;

Magnoni, Letizia ;

Scali, Carla ;

Massai, Luisa ;

Franceschini, Davide ;

Camarri, Michela ;

Gianfriddo, Marco ;

Diodato, Enrica ;

Thomas, Russell ;

Gokce, Ozgun ;

Tabrizi, S. J. ;

Caricasole, Andrea ;

Landwehrmeyer, Bernard ;

Menalled, Liliana ;

Murphy, Carol ;

Ramboz, Sylvie ;

Luthi-Carter, Ruth ;

Westerberg, Goran ;

Marsh, J. Lawrence .

HUMAN MOLECULAR GENETICS, 2014, 23 (11) :2995-3007

[66] Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage [J].

Solomon, JM ;

Pasupuleti, R ;

Xu, L ;

McDonagh, T ;

Curtis, R ;

DiStefano, PS ;

Huber, LJ .

MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) :28-38

[67]

Stein R.L., 2011, Kinetics of Enzyme Action: Essential Principles for Drug Hunters

[68] An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease [J].

Suessmuth, Sigurd D. ;

Haider, Salman ;

Landwehrmeyer, G. Bernhard ;

Farmer, Ruth ;

Frost, Chris ;

Tripepi, Giovanna ;

Andersen, Claus A. ;

Di Bacco, Marco ;

Lamanna, Claudia ;

Diodato, Enrica ;

Massai, Luisa ;

Diamanti, Daniela ;

Mori, Elisa ;

Magnoni, Letizia ;

Dreyhaupt, Jens ;

Schiefele, Karin ;

Craufurd, David ;

Saft, Carsten ;

Rudzinska, Monika ;

Ryglewicz, Danuta ;

Orth, Michael ;

Brzozy, Sebastian ;

Baran, Anna ;

Pollio, Giuseppe ;

Andre, Ralph ;

Tabrizi, Sarah J. ;

Darpo, Borje ;

Westerberg, Goran .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (03) :465-476

[69] Carbon monoxide ameliorates hepatic ischemia/reperfusion injury via sirtuin 1-mediated deacetylation of high-mobility group box 1 in rats [J].

Sun, Jian ;

Guo, Enshuang ;

Yang, Jiankun ;

Yang, Yan ;

Liu, Shenpei ;

Hu, Jifa ;

Jiang, Xiaojing ;

Dirsch, Olaf ;

Dahmen, Uta ;

Dong, Wei ;

Liu, Anding .

LIVER TRANSPLANTATION, 2017, 23 (04) :510-526

[70] Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors [J].

Suzuki, Takayoshi ;

Khan, Mohammed Naseer Ahmed ;

Sawada, Hideyuki ;

Imai, Erika ;

Itoh, Yukihiro ;

Yamatsuta, Katsura ;

Tokuda, Natsuko ;

Takeuchi, Jun ;

Seko, Takuya ;

Nakagawa, Hidehiko ;

Miyata, Naoki .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (12) :5760-5773

← 1 2 3 4 5 6 7 8 9 10 →